当前位置:首页 - 行情中心 - 博拓生物(688767) - 财务分析 - 现金流量表

博拓生物

(688767)

  

流通市值:58.28亿  总市值:58.28亿
流通股本:1.49亿   总股本:1.49亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金342,177,119.33242,376,948.27130,230,518.92497,647,512.6
  收到的税费返还19,300,948.667,270,887.414,837,527.5315,563,749.05
  收到其他与经营活动有关的现金31,319,736.516,562,411.069,504,453.9669,100,748.05
  经营活动现金流入小计392,797,804.49266,210,246.74144,572,500.41582,312,009.7
  购买商品、接受劳务支付的现金163,682,920.12109,148,301.4555,319,909.32257,201,923.77
  支付给职工以及为职工支付的现金88,408,999.5760,498,555.2633,397,141.48125,841,894.33
  支付的各项税费23,398,251.9920,292,655.513,105,840.2115,294,504.77
  支付其他与经营活动有关的现金43,234,150.8129,277,532.515,176,640.4555,148,248.17
  经营活动现金流出小计318,724,322.49219,217,044.71116,999,531.46453,486,571.04
  经营活动产生的现金流量净额74,073,48246,993,202.0327,572,968.95128,825,438.66
二、投资活动产生的现金流量:
  收回投资收到的现金4,336,866,6003,409,866,6002,196,124,8006,391,955,000
  取得投资收益收到的现金5,753,210.894,443,718.762,633,975.488,542,262.07
  处置固定资产、无形资产和其他长期资产收回的现金净额2,175,000265,000-80,589.98
  投资活动现金流入小计4,344,794,810.893,414,575,318.762,198,758,775.486,400,577,852.05
  购建固定资产、无形资产和其他长期资产支付的现金67,005,080.4719,987,707.699,966,824.62245,054,559.46
  投资支付的现金3,763,915,892.52,833,825,0001,639,124,8006,993,774,448.8
  投资活动现金流出小计3,830,920,972.972,853,812,707.691,649,091,624.627,238,829,008.26
  投资活动产生的现金流量净额513,873,837.92560,762,611.07549,667,150.86-838,251,156.21
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金3,147,5003,147,500-24,871,000
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计3,147,5003,147,500-24,871,000
  偿还债务支付的现金249,872.17211,721.07-148,252.84
  分配股利、利润或偿付利息支付的现金159,875,000.5159,875,000.553,208,333.583,645,463.2
  支付其他与筹资活动有关的现金1,325,772.721,325,772.72-45,630,753.55
  筹资活动现金流出小计161,450,645.39161,412,494.2953,208,333.5129,424,469.59
  筹资活动产生的现金流量净额-158,303,145.39-158,264,994.29-53,208,333.5-104,553,469.59
四、汇率变动对现金及现金等价物的影响-9,947,456.31-2,908,169.22-429,699.3210,499,922.62
五、现金及现金等价物净增加额419,696,718.22446,582,649.59523,602,086.99-803,479,264.52
  加:期初现金及现金等价物余额1,103,759,431.161,103,759,431.161,103,759,431.161,907,238,695.68
  期末现金及现金等价物余额1,523,456,149.381,550,342,080.751,627,361,518.151,103,759,431.16
补充资料:
  净利润-10,741,062.69-166,775,401.55
  资产减值准备-900,521.34-22,794,092.71
  固定资产和投资性房地产折旧-11,456,391.63-20,122,823.78
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-11,456,391.63-20,122,823.78
  无形资产摊销-2,860,886.89-1,144,069.23
  长期待摊费用摊销---108,266.15
  处置固定资产、无形资产和其他长期资产的损失--278,156.7-334,430.28
  固定资产报废损失-10,993.15--
  公允价值变动损失----257,796.83
  财务费用-2,342,569.22--9,100,169.71
  投资损失--3,124,451.6--6,789,817.56
  递延所得税-668,655.75-1,937,045.92
  其中:递延所得税资产减少-668,655.75-2,645,376.54
    递延所得税负债增加----708,330.62
  存货的减少-1,441,308.85-3,128,800.1
  经营性应收项目的减少-20,640,388.09--39,775,742.43
  经营性应付项目的增加--7,977,288.57--43,094,634.93
  其他-8,584,106.85-6,525,651.84
  现金的期末余额-1,550,342,080.75-1,103,759,431.16
  减:现金的期初余额-1,103,759,431.16-1,907,238,695.68
  现金及现金等价物的净增加额-446,582,649.59--803,479,264.52
公告日期2025-10-302025-08-292025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑